1. Avdeev, S.N., Beloborodov, V.B., Omel’yanovskii, V.V., et al., Vremennye Metodicheskie Rekomendatsii. Profilaktika, Diagnostika i Lechenie Novoi Koronavirusnoi Infektsii (COVID-19). Versiya 9 (26.10.20) (Interim Methodological Recommendations. Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection (COVID-19)), Ministrestvo Zdravookhraneniya Rossiiskoi Federatsii, 2020.
2. Chamsutdinov, N.U. and Abdulmanapova, D.N., Tactics for treating patients with novel coronavirus infection (COVID-19): Unresolved problems of pulmonology, Vestnik DGMA, 2021, vol. 3, no. 40, pp. 42–54.
3. Van Bambeke, F., Michot, J.M., Van Eldere, J., et al., Quinolones in 2005: An update // clinical microbiology and infection, Clin. Microbiol. Infect., 2005, vol. 11, no. 4, pp. 256–280.
4. Owens, H.M. and Dash, A.K., Comprehensive Profile, Profiles Drug Subst., Excipients, Relat. Methodol., 2003, vol. 30, no. 03, pp. 21–57.
5. Davis, M.E. and Brewster, M.E., Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug Discovery, 2004, vol. 3, no. 12, pp. 1023–1035.